(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are BORGESTAD, POLIGHT, and NAPATECH.

Financial Asset	Price	Change	Updated (EST)
BORGESTAD (BOR.OL)	18.40	13.58%	2024-06-13 12:27:10
POLIGHT (PLT.OL)	4.17	7.83%	2024-06-13 12:43:22
NAPATECH (NAPA.OL)	35.60	7.55%	2024-06-13 12:41:15
PEXIP HOLDING (PEXIP.OL)	31.80	5.47%	2024-06-13 12:43:15
GRIEG SEAFOOD (GSF.OL)	73.55	5.45%	2024-06-13 12:40:17
PCI BIOTECH HOLD (PCIB.OL)	2.11	5.28%	2024-06-13 12:43:10
DGB GROUP N.V. (DGB.AS)	0.69	4.55%	2024-06-13 12:01:36
CLOUDBERRY CLEAN (CLOUD.OL)	10.68	4.5%	2024-06-13 12:27:28
IMMO MCC (MCC.BR)	450.00	4.17%	2024-06-13 12:20:17
ENVIPCO (ENVI.AS)	6.40	4.07%	2024-06-13 12:01:53

The three biggest losers today are VIVORYON, BASILIX CERT, and KEYWARE TECH..

Financial Asset	Price	Change	Updated (EST)
VIVORYON (VVY.AS)	2.19	-10.45%	2024-06-13 12:04:34
BASILIX CERT (BAS.BR)	10.30	-9.65%	2024-06-13 12:05:09
KEYWARE TECH. (KEYW.BR)	0.79	-6.51%	2024-06-13 12:21:09
INTEROIL EXPL PROD (IOX.OL)	6.35	-6.19%	2024-06-13 12:40:35
BEVER HOLDING (BEVER.AS)	2.52	-5.97%	2024-06-13 12:00:59
BENEVOLENTAI (BAI.AS)	0.52	-5.45%	2024-06-13 12:00:55
ADOCIA (ADOC.PA)	7.90	-5.39%	2024-06-13 12:46:00
VOW (VOW.OL)	6.46	-5.33%	2024-06-13 12:45:16
NX FILTRATION (NXFIL.AS)	4.71	-5.33%	2024-06-13 12:03:15
PB HOLDING (PBH.AS)	2.92	-4.58%	2024-06-13 12:03:21

Winners today

1. BORGESTAD (BOR.OL)

13.58% Price Change

Borgestad ASA develops, manufactures, distributes, delivers, and installs refractory products in Norway. The company also develops and manages real estate properties. It operates Agora Bytom, a shopping center and a rental area, as well as a parking garage with parking spaces in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD jumping 13.58% to €18.40 on Thursday while Oslo Børs Benchmark Index_GI slid 1% to €1,400.14.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.96.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Moving Average

BORGESTAD’s worth is way above its 50-day moving average of kr1.50 and way above its 200-day moving average of kr1.46.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BORGESTAD’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 400% and 100%, respectively.

Volatility

BORGESTAD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.91%, a negative 0.74%, and a positive 3.01%.

BORGESTAD’s highest amplitude of average volatility was 3.55% (last week), 3.56% (last month), and 3.01% (last quarter).

More news about BORGESTAD.

2. POLIGHT (PLT.OL)

7.83% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 7.83% to €4.17 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 1% to €1,400.14, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Moving Average

POLIGHT’s worth is way above its 50-day moving average of kr2.98 and way under its 200-day moving average of kr11.09.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POLIGHT’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for POLIGHT is 3362450 which is 104.61% above its average volume of 1643270.

Yearly Top and Bottom Value

POLIGHT’s stock is valued at kr4.17 at 22:40 EST, way below its 52-week high of kr25.70 and way higher than its 52-week low of kr2.34.

More news about POLIGHT.

3. NAPATECH (NAPA.OL)

7.55% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. Napatech A/S was incorporated in 2003 and is based in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH jumping 7.55% to €35.60 on Thursday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI dropped 1% to €1,400.14, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.

Moving Average

NAPATECH’s value is way higher than its 50-day moving average of kr27.56 and way higher than its 200-day moving average of kr17.04.

More news about NAPATECH.

4. PEXIP HOLDING (PEXIP.OL)

5.47% Price Change

Pexip Holding ASA, a video technology company, provides end-to-end video conferencing platform and digital infrastructure worldwide. It offers self-hosted software application and as-a-service deployment options for enterprise video conferencing, built on its proprietary Infinity technology. The company also enables any meeting room device, such as Cisco Webex, HP/Poly, and Microsoft Teams Rooms to connect to any meeting technology, including Meet, Teams, and Zoom in the Connected Spaces solutions area as an interoperability provider. It serves government, public sector, healthcare, judicial, finance, military, and defense sectors. The company was founded in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PEXIP HOLDING rising 5.47% to €31.80 on Thursday, after three successive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 1% to €1,400.14, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, PEXIP HOLDING has a trailing twelve months EPS of kr-0.57.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.47%.

Moving Average

PEXIP HOLDING’s worth is higher than its 50-day moving average of kr29.08 and way higher than its 200-day moving average of kr24.61.

Volume

Today’s last reported volume for PEXIP HOLDING is 338715 which is 38.6% above its average volume of 244379.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PEXIP HOLDING’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 12%, now sitting on 1.02B for the twelve trailing months.

More news about PEXIP HOLDING.

5. GRIEG SEAFOOD (GSF.OL)

5.45% Price Change

Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, the United Kingdom, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the farming, production, and sale of Atlantic salmon. The company was incorporated in 1988 and is headquartered in Bergen, Norway. Grieg Seafood ASA is a subsidiary of Grieg Aqua AS.

Oslo Børs Benchmark Index_GI ended the session with GRIEG SEAFOOD rising 5.45% to €73.55 on Thursday while Oslo Børs Benchmark Index_GI fell 1% to €1,400.14.

Earnings Per Share

As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr-1.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.95%.

More news about GRIEG SEAFOOD.

6. PCI BIOTECH HOLD (PCIB.OL)

5.28% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 5.28% to €2.11 on Thursday while Oslo Børs Benchmark Index_GI slid 1% to €1,400.14.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr2.11 at 22:40 EST, way below its 52-week high of kr3.50 and way higher than its 52-week low of kr1.20.

Volume

Today’s last reported volume for PCI BIOTECH HOLD is 105404 which is 78.59% below its average volume of 492513.

Volatility

PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.31%, a positive 1.94%, and a positive 5.26%.

PCI BIOTECH HOLD’s highest amplitude of average volatility was 1.95% (last week), 10.06% (last month), and 5.26% (last quarter).

Moving Average

PCI BIOTECH HOLD’s value is way higher than its 50-day moving average of kr1.76 and way higher than its 200-day moving average of kr1.91.

More news about PCI BIOTECH HOLD.

7. DGB GROUP N.V. (DGB.AS)

4.55% Price Change

DGB Group N.V. invests in, develops, and manages carbon credits and biodiversity projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising removing or avoiding carbon emissions, tackling social, and environmental challenges; manages projects that focuses on ecosystem restoration, habitat conservation, and biodiversity enrichment; and undertakes plastic projects, which consists of removing and recycling plastic, waste reduction, and environmental conservation works, as well as carbon offsetting projects for reducing carbon footprint of companies. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. jumping 4.55% to €0.69 on Thursday while AEX-Index slid 0.77% to €924.61.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.73%.

Volatility

DGB GROUP N.V.’s last week, last month’s, and last quarter’s current intraday variation average was 0.46%, 1.65%, and 3.75%.

DGB GROUP N.V.’s highest amplitude of average volatility was 4.36% (last week), 4.81% (last month), and 3.75% (last quarter).

Yearly Top and Bottom Value

DGB GROUP N.V.’s stock is valued at €0.69 at 22:40 EST, way under its 52-week high of €0.78 and way higher than its 52-week low of €0.38.

More news about DGB GROUP N.V..

8. CLOUDBERRY CLEAN (CLOUD.OL)

4.5% Price Change

Cloudberry Clean Energy ASA operates as a renewable energy company. The company operates through four segments: Production, Development, Operations and Corporate. It engages in the ownership, development, and operation of hydropower plants and wind farms in Norway, Sweden, and Denmark. The company was incorporated in 2017 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CLOUDBERRY CLEAN rising 4.5% to €10.68 on Thursday while Oslo Børs Benchmark Index_GI slid 1% to €1,400.14.

Earnings Per Share

As for profitability, CLOUDBERRY CLEAN has a trailing twelve months EPS of kr0.57.

PE Ratio

CLOUDBERRY CLEAN has a trailing twelve months price to earnings ratio of 18.74. Meaning, the purchaser of the share is investing kr18.74 for every norwegian krone of annual earnings.

Volume

Today’s last reported volume for CLOUDBERRY CLEAN is 167006 which is 43.73% below its average volume of 296818.

More news about CLOUDBERRY CLEAN.

9. IMMO MCC (MCC.BR)

4.17% Price Change

Immo Mechelen City Center Naamloze vennootschap operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with IMMO MCC rising 4.17% to €450.00 on Thursday while BEL 20 fell 0.97% to €3,868.77.

Volatility

IMMO MCC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.76%, a negative 0.62%, and a positive 1.58%.

IMMO MCC’s highest amplitude of average volatility was 6.78% (last week), 2.86% (last month), and 1.58% (last quarter).

Moving Average

IMMO MCC’s value is below its 50-day moving average of €472.00 and under its 200-day moving average of €481.03.

More news about IMMO MCC.

10. ENVIPCO (ENVI.AS)

4.07% Price Change

Envipco Holding N.V., together with its subsidiaries, designs, develops, manufactures, and sells or leases reverse vending machines (RVM) for the collection and processing of used beverage containers primarily in the Netherlands, North America, and Europe. The company provides technical support, RVM maintenance, and accounting services to the retail stores, bottlers, and distributors for containers redeemed through its machines. It also offers deposit, handling fees, scrap reconciliations, commodity brokerage, clearing house functions, and accounting services. In addition, the company provides materials handling services primarily in the northeastern part of the United States. Envipco Holding N.V. was incorporated in 1998 and is headquartered in Amersfoort, the Netherlands.

AEX-Index ended the session with ENVIPCO rising 4.07% to €6.40 on Thursday, following the last session’s downward trend. AEX-Index slid 0.77% to €924.61, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ENVIPCO has a trailing twelve months EPS of €-0.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.69%.

Volume

Today’s last reported volume for ENVIPCO is 21615 which is 28.63% below its average volume of 30288.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENVIPCO’s stock is considered to be oversold (<=20).

Volatility

ENVIPCO’s last week, last month’s, and last quarter’s current intraday variation average was 1.13%, 0.29%, and 3.30%.

ENVIPCO’s highest amplitude of average volatility was 2.83% (last week), 2.70% (last month), and 3.30% (last quarter).

Sales Growth

ENVIPCO’s sales growth is 96% for the ongoing quarter and 39.8% for the next.

More news about ENVIPCO.

Losers Today

1. VIVORYON (VVY.AS)

-10.45% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON dropping 10.45% to €2.19 on Thursday while AEX-Index dropped 0.77% to €924.61.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Volatility

VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.46%, a positive 5.46%, and a positive 7.57%.

VIVORYON’s highest amplitude of average volatility was 1.66% (last week), 11.74% (last month), and 7.57% (last quarter).

Volume

Today’s last reported volume for VIVORYON is 785988 which is 28.84% below its average volume of 1104630.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VIVORYON’s stock is considered to be overbought (>=80).

More news about VIVORYON.

2. BASILIX CERT (BAS.BR)

-9.65% Price Change

Basilix Cert owns and operates a shopping center in Belgium. The company operates accessories, feed, beauty, jewelry, fashion, multimedia, and house shops, as well as restaurants. It offers products of approximately 40 brands. The company was founded in 1984 and is based in Brussels, Belgium. Basilix Cert is a subsidiary of KBC Bank NV. Basilix Cert operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BASILIX CERT falling 9.65% to €10.30 on Thursday while BEL 20 fell 0.97% to €3,868.77.

Earnings Per Share

As for profitability, BASILIX CERT has a trailing twelve months EPS of €-0.58.

More news about BASILIX CERT.

3. KEYWARE TECH. (KEYW.BR)

-6.51% Price Change

Keyware Technologies NV, an independent fintech company, provides electronic payments processing and management solutions in Belgium. It offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and payment processing and management services, as well as rents and sells payment terminals. The company was incorporated in 1996 and is headquartered in Zaventem, Belgium.

BEL 20 ended the session with KEYWARE TECH. dropping 6.51% to €0.79 on Thursday, following the last session’s upward trend. BEL 20 dropped 0.97% to €3,868.77, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, KEYWARE TECH. has a trailing twelve months EPS of €0.01.

PE Ratio

KEYWARE TECH. has a trailing twelve months price to earnings ratio of 79. Meaning, the purchaser of the share is investing €79 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.98%.

More news about KEYWARE TECH..

4. INTEROIL EXPL PROD (IOX.OL)

-6.19% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD falling 6.19% to €6.35 on Thursday while Oslo Børs Benchmark Index_GI dropped 1% to €1,400.14.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 211.7. Meaning, the purchaser of the share is investing kr211.7 for every norwegian krone of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 206.4%, now sitting on 24.45M for the twelve trailing months.

Yearly Top and Bottom Value

INTEROIL EXPL PROD’s stock is valued at kr6.35 at 22:40 EST, way below its 52-week high of kr11.00 and way higher than its 52-week low of kr1.75.

More news about INTEROIL EXPL PROD.

5. BEVER HOLDING (BEVER.AS)

-5.97% Price Change

Bever Holding NV operates as a real estate company in the Netherlands and Belgium. The company develops residential and non-residential properties. It also invests in, acquires, and leases real estate properties. The company was incorporated in 1975 and is based in Wassenaar, the Netherlands.

AEX-Index ended the session with BEVER HOLDING dropping 5.97% to €2.52 on Thursday while AEX-Index fell 0.77% to €924.61.

Earnings Per Share

As for profitability, BEVER HOLDING has a trailing twelve months EPS of €-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.54%.

Yearly Top and Bottom Value

BEVER HOLDING’s stock is valued at €2.52 at 22:40 EST, way under its 52-week high of €3.00 and above its 52-week low of €2.40.

Revenue Growth

Year-on-year quarterly revenue growth declined by 11.4%, now sitting on 2k for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEVER HOLDING’s stock is considered to be overbought (>=80).

More news about BEVER HOLDING.

6. BENEVOLENTAI (BAI.AS)

-5.45% Price Change

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson's disease. It has collaboration agreements with AstraZeneca and Merck to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI dropping 5.45% to €0.52 on Thursday, following the last session’s upward trend. AEX-Index slid 0.77% to €924.61, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.63.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.01%.

More news about BENEVOLENTAI.

7. ADOCIA (ADOC.PA)

-5.39% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA sliding 5.39% to €7.90 on Thursday, following the last session’s upward trend. CAC 40 slid 1.99% to €7,708.02, following the last session’s upward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

More news about ADOCIA.

8. VOW (VOW.OL)

-5.33% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW falling 5.33% to €6.46 on Thursday while Oslo Børs Benchmark Index_GI slid 1% to €1,400.14.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.86%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VOW’s stock is considered to be oversold (<=20).

Sales Growth

VOW’s sales growth is 108.9% for the present quarter and 82.6% for the next.

Yearly Top and Bottom Value

VOW’s stock is valued at kr6.46 at 22:40 EST, way under its 52-week high of kr17.80 and way higher than its 52-week low of kr4.80.

More news about VOW.

9. NX FILTRATION (NXFIL.AS)

-5.33% Price Change

NX Filtration N.V. develops, manufactures, and sells hollow fiber membrane modules in Netherlands, Europe, North America, Asia, and internationally. The company offers direct nanofiltration, ultrafiltration, and microfiltration membrane modules that remove bacteria, viruses, micropollutants, color, and selective salts from water without pre-treatment and use of chemicals. It provides HYDRAcap ultrafiltration modules to treat surface water, ground water, sedawater, and wastewaters as pretreatment to reverse osmosis and nanofiltration; and Projection Tool, and intuitive and online platform that enables the rapid and iterative system design for dNF membranes. In addition, the company offers integrated rack design and testing and piloting services. The company was incorporated in 2016 and is headquartered in Enschede, the Netherlands.

AEX-Index ended the session with NX FILTRATION dropping 5.33% to €4.71 on Thursday while AEX-Index slid 0.77% to €924.61.

Earnings Per Share

As for profitability, NX FILTRATION has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.78%.

Volume

Today’s last reported volume for NX FILTRATION is 127243 which is 55.52% below its average volume of 286122.

More news about NX FILTRATION.

10. PB HOLDING (PBH.AS)

-4.58% Price Change

PB Holding N.V. provides financial services. The company was formerly known as Stern Groep N.V. and changed its name to PB Holding N.V. in March 2022. PB Holding N.V. is headquartered in Huizen, the Netherlands.

AEX-Index ended the session with PB HOLDING falling 4.58% to €2.92 on Thursday while AEX-Index dropped 0.77% to €924.61.

Earnings Per Share

As for profitability, PB HOLDING has a trailing twelve months EPS of €-0.46.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.61%.

More news about PB HOLDING.

Stay up to date with our winners and losers daily report